ongo
worldwid
epidem
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
pose
huge
threat
global
public
health
howev
regard
effect
inflammatori
marker
sever
studi
report
associ
vari
strength
direct
metaanalysi
aim
provid
overview
associ
inflammatori
marker
sever
follow
databas
search
pubm
embas
cochran
librari
wanfang
databas
cnki
china
nation
knowledg
infrastructur
databas
march
weight
mean
differ
wmd
confid
interv
ci
pool
use
random
fixedeffect
model
total
studi
includ
analysi
compris
patient
randomeffect
result
demonstr
patient
nonsever
group
lower
level
crp
wmd
mgl
ci
p
pct
wmd
ngml
ci
p
wmd
ngl
ci
p
esr
wmd
mmh
ci
p
saa
wmd
ci
p
serum
ferritin
wmd
mgl
ci
p
compar
sever
group
moreov
survivor
lower
level
nonsurvivor
wmd
ngml
ci
p
result
consist
sensit
analysi
public
bia
assess
metaanalysi
highlight
associ
inflammatori
marker
sever
measur
inflammatori
marker
might
help
clinician
monitor
evalu
sever
prognosi
ongo
worldwid
pandem
coronaviru
diseas
pose
huge
threat
global
public
health
pathogen
identifi
novel
singlestrand
ribonucl
acid
rna
betacoronaviru
name
sever
acut
respiratori
syndrom
coronaviru
share
great
phylogenet
similar
sever
acut
respiratori
syndrom
coronaviru
sarscov
zhou
p
et
al
march
total
confirm
case
countri
territori
report
includ
death
repres
spectrum
clinic
sever
rang
asymptomat
critic
pneumonia
acut
respiratori
distress
syndrom
ard
even
death
guan
et
al
therefor
fulli
monitor
sever
effect
earli
intervent
fundament
measur
reduc
mortal
accumul
evid
suggest
inflammatori
respons
play
critic
role
progress
sever
marker
trace
detect
accuraci
diseas
sever
fatal
mehta
et
al
steb
et
al
inflammatori
marker
procalcitonin
pct
serum
ferritin
erythrocyt
sediment
rate
esr
acut
phase
reactant
protein
c
reactiv
protein
crp
report
significantli
associ
highrisk
develop
sever
cheng
et
al
gao
et
al
qin
et
al
moreov
increas
level
serum
amyloid
saa
shown
involv
pathogenesi
may
serv
potenti
biomark
monitor
diseas
progress
cheng
et
al
xiang
et
al
howev
result
remain
controversi
due
observ
differ
level
saa
esr
crp
studi
best
knowledg
overal
inflammatori
profil
todat
miss
due
insuffici
sampl
size
perform
analysi
current
scientif
literatur
provid
overview
associ
inflammatori
marker
sever
patient
metaanalysi
perform
accord
prefer
report
item
systemat
review
metaanalys
prisma
guidelin
origin
studi
report
search
march
pubm
embas
cochran
librari
wanfang
databas
cnki
china
nation
knowledg
infrastructur
databas
follow
combin
search
term
use
novel
coronaviru
wuhan
viru
chines
viru
elig
articl
retriev
refer
identifi
public
search
potenti
relev
articl
gao
et
al
zhou
f
et
al
englishlanguag
chineselanguag
public
report
concentr
inflamm
marker
patient
includ
met
follow
criteria
patient
could
group
sever
nonsever
nonintens
care
unit
icu
group
icu
group
survivor
nonsurvivor
literatur
sourc
necessari
data
avail
diagnost
criteria
clarifi
base
laboratoryconfirm
infect
two
studi
author
institut
studi
largest
sampl
size
chosen
studi
exclud
full
text
trial
avail
fulfil
inclus
criteria
record
initi
search
scan
two
author
exclud
duplic
irrelev
studi
follow
data
extract
first
author
public
date
countri
origin
group
situat
case
age
sex
level
inflammatori
marker
differ
group
stratifi
data
interquartil
rang
iqr
convert
mean
use
mathemat
formula
metaanalysi
luo
et
al
wan
et
al
discrep
resolv
discuss
qualiti
assess
potenti
elig
studi
conduct
use
newcastleottawa
scale
no
eight
item
three
aspect
select
compar
exposur
full
score
star
four
six
star
regard
moderatequ
studi
seven
nine
star
highqual
studi
studi
no
score
lower
recogn
inferior
qualiti
therefor
exclud
statist
analys
carri
stata
version
stata
corpor
colleg
station
tx
usa
softwar
statist
heterogen
assess
pvalu
fix
effect
model
adopt
without
signific
heterogen
p
random
effect
model
employ
instanc
p
zeng
et
al
zeng
et
al
weight
mean
differ
wmd
confid
interv
ci
calcul
inflammatori
marker
sensit
analysi
perform
omit
one
studi
time
influenc
analysi
assess
stabil
result
besid
standard
mean
differ
smd
use
explor
consist
conclus
public
bia
evalu
egger
test
public
bia
conform
duval
trim
fill
method
implement
adjust
bia
p
consid
statist
signific
initi
literatur
search
gener
altogeth
record
studi
subsequ
exclud
due
duplic
figur
review
titl
abstract
obtain
studi
exclud
addit
studi
exclud
studi
scan
full
text
report
inflammatori
marker
final
studi
includ
analysi
chang
et
al
cheng
et
al
gao
et
al
huang
et
al
peng
et
al
qin
et
al
ruan
et
al
xiang
et
al
xiao
et
al
zhou
f
et
al
characterist
elig
studi
present
tabl
studi
come
china
publish
involv
patient
studi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
group
nonsever
sever
group
studi
group
nonicu
icu
group
studi
group
survivor
nonsurvivor
obvious
patient
sever
group
icu
group
nonsurvivor
group
older
age
correspond
control
group
obviou
differ
sex
distribut
patient
studi
studi
deem
high
qualiti
no
score
detail
could
found
tabl
addit
one
studi
level
fibrinogen
nonsever
group
sever
group
one
studi
level
pct
nonicu
group
icu
group
one
studi
level
crp
pct
nonsurvivor
survivor
includ
metaanalysi
due
inadequ
data
howev
result
report
studi
consist
pool
result
metaanalys
strong
evid
heterogen
found
comparison
figur
sensit
analys
indic
result
influenc
exclud
one
specif
studi
crp
pct
esr
nonsever
sever
group
figur
saa
serum
ferritin
conclus
chang
delet
cheng
k
studi
qin
c
studi
separ
heterogen
becom
larger
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
suggest
better
keep
studi
metaanalysi
figur
egger
test
conduct
evalu
public
bia
tabl
tabl
caus
rapidli
expand
worldwid
despit
case
mild
symptom
good
prognosi
develop
ard
even
death
date
effect
therapi
de
clercq
russel
et
al
therefor
imper
identifi
marker
monitor
progress
diseas
treat
patient
earli
sever
studi
shown
increas
proinflammatori
cytokin
serum
patient
also
antiinflammatori
agent
therapi
highlight
critic
role
inflamm
progress
mehta
et
al
steb
et
al
howev
role
inflammatori
marker
monitor
sever
still
controversi
studi
analyz
retrospect
studi
conclud
inflammatori
marker
especi
crp
pct
esr
posit
correl
sever
implic
sar
outbreak
avian
influenza
infect
law
et
al
saito
et
al
recent
studi
show
granulocytemacrophag
coloni
stimul
factor
gmcsf
could
secret
activ
pathogen
cell
upon
infect
also
inflammatori
monocyt
activ
gmcsf
could
secret
inflammatori
factor
zhou
yonggang
et
al
accord
new
coronaviru
pneumonia
prevent
control
program
edit
publish
nation
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
health
commiss
china
decreas
level
indic
deterior
studi
firstli
provid
evidencebas
medicin
evid
metaanalysi
moreov
level
could
routin
detect
mani
hospit
china
inflammatori
marker
crp
pct
esr
usual
could
detect
studi
firstli
put
forward
besid
inflammatori
marker
crp
pct
esr
also
posit
correl
sever
conclus
consist
sensit
analysi
public
bia
assess
crp
exquisit
sensit
system
marker
acutephas
respons
inflamm
infect
tissu
damag
could
use
indic
inflamm
pepi
hirschfield
chen
l
et
al
studi
although
statist
signific
differ
found
level
crp
nonsever
sever
group
mean
level
crp
higher
sever
group
nonsever
group
studi
report
crp
level
posit
relat
sever
pct
also
main
inflammatori
marker
routin
measur
clinic
practic
among
studi
level
pct
higher
sever
group
nonsever
group
esr
nonspecif
inflammatori
marker
mainli
reflect
chang
plasma
protein
type
wu
et
al
metaanalysi
found
higher
esr
level
sever
group
nonsever
group
one
reason
patient
sever
group
higher
inflamm
anoth
possibl
explan
patient
older
age
sever
group
contribut
higher
level
esr
consid
level
esr
increas
age
piva
et
al
also
found
patient
sever
group
higher
level
saa
serum
ferritin
nonsever
group
consid
three
studi
report
level
sensit
analysi
chang
conclus
temporarili
could
conclud
associ
sever
saa
sensit
acut
respons
protein
use
sensit
index
reflect
control
infect
inflamm
serum
ferritin
surrog
marker
store
iron
increas
inflamm
liver
diseas
malign
cohen
et
al
facciorusso
et
al
kowdley
et
al
highlight
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
overexuber
inflammatori
respons
associ
sever
knowledg
first
metaanalysi
associ
seri
inflammatori
marker
sever
admittedli
metaanalysi
limit
firstli
notic
heterogen
exist
analys
sensit
analysi
smd
use
metaanalysi
yet
heterogen
could
elimin
complet
secondli
report
public
bia
may
result
lack
inform
unpublish
neg
studi
though
conclus
chang
trimandfil
method
thirdli
studi
includ
metaanalysi
mainli
china
whether
conclus
consist
countri
need
investig
final
underpow
investig
underli
mechan
inflammatori
marker
sever
conclus
inflammatori
marker
especi
crp
pct
esr
posit
correl
sever
associ
saa
serum
ferritin
sever
need
clarifi
measur
inflammatori
marker
might
help
clinician
monitor
evalu
sever
prognosi
fz
gd
respons
studi
design
write
yg
collect
data
gd
analyz
data
xc
revis
manuscript
research
fund
grant
nation
natur
scienc
foundat
china
approv
requir
author
declar
conflict
interest
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
